文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

英格兰、威尔士和北爱尔兰第一波COVID-19重症监护流行病学

COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland.
PubMed 文献 · Intensive Care Med · 2020-10-09
一句话结论首波COVID-19重症患者以男性、非白人、肥胖者为主,急性院內死亡率42%,远高于其他病毒性肺炎的24.7%。

该研究基于Case Mix Programme国家成人重症监护审计数据,前瞻性纳入2020年2月至8月英格兰、威尔士和北爱尔兰289个重症监护单元的10,834例COVID-19患者,并与2017-2019年5,782例其他病毒性肺炎(非COVID-19)患者进行回顾性比较。COVID-19患者中70.1%为男性,中位年龄60岁,32.6%为非白人,39.4%肥胖;36.9%患者PaO2/FiO2≤13.3 kPa(≤100 mmHg),72%接受有创通气。急性院內死亡率为42%,显著高于其他病毒性肺炎的24.7%,且88.7%的死亡发生在30天内。结论指出常规严重度评分似乎不能充分反映其急性严重程度,国际比较因缺乏标准化报告而受限。

要点

  • COVID-19重症患者急性院內死亡率为42%,高于其他病毒性肺炎患者的24.7%,且88.7%的死亡发生在30天内。
  • 36.9%的COVID-19重症患者PaO2/FiO2≤13.3 kPa(≤100 mmHg),符合重度ARDS,72%接受了有创通气。
  • 患者特征:70.1%男性,中位年龄60岁,32.6%非白人,39.4%肥胖,仅8.2%有至少一种严重合并症。
  • 常规严重度评分似乎不能充分反映COVID-19患者的急性严重程度,PaO2/FiO2分类分布提示急性重症呼吸疾病。
  • 国际比较因缺乏标准化报告而受限,需注意不同队列间可比性问题。

适用人群与场景

  • 纳入:2020年2月至8月英格兰、威尔士和北爱尔兰289个重症监护单元收治的成人COVID-19重症患者(10,834例)。
  • 对照:2017-2019年5782例其他病毒性肺炎(非COVID-19)成人重症监护患者(回顾性队列)。

诊断标准与关键阈值

  • 重度ARDS界定:PaO2/FiO2≤13.3 kPa(≤100 mmHg),36.9%的COVID-19患者符合此阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:前瞻性队列(COVID-19)与回顾性队列(非COVID-19其他病毒性肺炎)比较,并描述性对比已发表国际COVID-19队列;COVID-19队列来自289个重症监护单元,共10,834例。
  • COVID-19队列特征:70.1%男性,中位年龄60岁,32.6%非白人,39.4%肥胖,8.2%至少一种严重合并症;36.9% PaO2/FiO2≤13.3 kPa(≤100 mmHg),72%接受有创通气。
  • 主要终点:COVID-19患者急性院內死亡率为42%,其他病毒性肺炎(非COVID-19)患者为24.7%;88.7%的COVID-19死亡发生在30天前。
  • 国际比较因缺乏标准化报告而受限。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究(COVID-19)与回顾性队列(非COVID-19)比较,并描述性对比已发表国际队列;原文未给出证据等级或推荐强度。
  • 局限:原文明确述及国际比较因缺乏标准化报告而受限;未述及其他局限性。

对床旁实践的改变

  • 原文提示常规严重度评分似乎不能充分反映COVID-19重症患者的急性严重程度,床旁评估需结合PaO2/FiO2等呼吸指标。
  • COVID-19重症患者急性院內死亡率高(42%),且多数死亡发生在30天内,资源规划需考虑高负担。
  • 患者以男性、非白人、肥胖者比例较高,但原文未提出针对这些特征的特定干预建议。

指南或共识出处

  • Intensive Care Med(原文未提供具体指南或共识名称)

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

PURPOSE: To describe critical care patients with COVID-19 across England, Wales and Northern Ireland and compare them with a historic cohort of patients with other viral pneumonias (non-COVID-19) and with international cohorts of COVID-19.

METHODS: Extracted data on patient characteristics, acute illness severity, organ support and outcomes from the Case Mix Programme, the national clinical audit for adult critical care, for a prospective cohort of patients with COVID-19 (February to August 2020) are compared with a recent retrospective cohort of patients with other viral pneumonias (non-COVID-19) (2017-2019) and with other international cohorts of critical care patients with COVID-19, the latter identified from published reports.

RESULTS: 10,834 patients with COVID-19 (70.1% male, median age 60 years, 32.6% non-white ethnicity, 39.4% obese, 8.2% at least one serious comorbidity) were admitted across 289 critical care units. Of these, 36.9% had a PaO2/FiO2 ratio of ≤ 13.3 kPa (≤ 100 mmHg) consistent with severe ARDS and 72% received invasive ventilation. Acute hospital mortality was 42%, higher than for 5782 critical care patients with other viral pneumonias (non-COVID-19) (24.7%), and most COVID-19 deaths (88.7%) occurred before 30 days. Meaningful international comparisons were limited due to lack of standardised reporting.

CONCLUSION: Critical care patients with COVID-19 were disproportionately non-white, from more deprived areas and more likely to be male and obese. Conventional severity scoring appeared not to adequately reflect their acute severity, with the distribution across PaO2/FiO2 ratio categories indicating acutely severe respiratory disease. Critical care patients with COVID-19 experience high mortality and place a great burden on critical care services.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Richards-Belle A, Orzechowska I, Gould DW, et al. COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland. Intensive Care Med. 2020. PMID: 33034689. doi:10.1007/s00134-020-06267-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。